Original article by Kate Hagan
The Age – Page: 13 : 29-Oct-14

A new study published in the "Molecular Psychiatry" journal shows that scientists at the University of Melbourne have developed a new advance test for Alzheimer’s disease. They found that looking at micro ribonucleic acid in blood samples allows doctors to identify individuals with a certain genetic signature, which indicates they either already have the disease or are likely to develop it later in life. Further trials will be conducted, but at present the success rate of the test is 91%. Early diagnosis is crucial for Alzheimer’s as there is no cure available

CORPORATES
UNIVERSITY OF MELBOURNE, KING’S COLLEGE LONDON